Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Pfizer (PFE) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...

Pfizer (PFE) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Shares ...

Pfizer stock offers a yield above 6% at recent prices. MPLX LP is a pipeline operator that offers a yield above 7% at the moment. Pfizer and MPLX LP could continue raising their dividend payouts for ...

Unlike peers, GSK plc faces limited Loss of Exclusivity risk, supporting steady revenue projections and justifying higher ...

The Dividend Harvesting Portfolio achieved 28.75% returns and strong income in a volatile market. Read here for an investment ...

Key Insights The considerable ownership by retail investors in Pyxis Oncology indicates that they collectively have ...

With Washington closed after Tuesday's congressional impasse, markets are left in a bit of quandary about how to interpret the hiatus and which economic data to focus on if this week's key jobs ...

This sustained sell-off has wiped out approximately $18 billion in market capitalization, leaving its current value at around ...

Pfizer's stock has been struggling for multiple years, and even a low valuation hasn't made it an enticing option for many ...

After its best day in nearly four years Tuesday, Pfizer stock gave an encore performance. Shares of the drugmaker closed up 6.8% as investors digested Tuesday's news that Pfizer would get a three-year ...

Investors continued to be positive on the pharmaceutical giant following a deal reached with the government. Among other benefits, it will have a reprieve from potential tariffs on its industry. A ...